

Health Library
October 10, 2025
Question on this topic? Get an instant answer from August.
Brigatinib ni umuti w'indwara ya kanseri ugamije kuvura ubwoko bwihariye bwa kanseri y'ibihaha yitwa ALK-positive non-small cell lung cancer. Uyu muti wandikirwa na muganga ukora ubugenzuzi bwa poroteyine zihariye zifasha selile za kanseri gukura no gukwirakwira mu mubiri wawe.
Niba wowe cyangwa umuntu witaweho yarandikiwe brigatinib, birashoboka ko ushaka amakuru asobanutse kandi yizewe ku byo witegura. Reka tunyuremo ibyo ukeneye kumenya byose kuri uyu muti mu buryo bworoshye kandi butanga icyizere.
Brigatinib ni mu cyiciro cy'imiti yitwa kinase inhibitors, aribyo bivura kanseri. Bitekereze nk'igikoresho cy'ubuhanga aho kuba ubuvuzi bwagutse—bugamije by'umwihariko selile za kanseri zifite ihinduka ryihariye rya genetike ryitwa ALK rearrangement.
Uyu muti uza mu buryo bw'ibinini bifatirwa mu kanwa, bigatuma byoroha kurusha ubuvuzi bwa kanseri bwa kera busaba gusura ibitaro kugira ngo baterwe imiti. Uyu muti watejwe imbere kugira ngo ukore neza ku selile za kanseri y'ibihaha zamaze kwanga izindi miti ya ALK inhibitors.
Muganga wawe w'inzobere mu kuvura kanseri azagusaba brigatinib nyuma yo kwemeza binyuze mu igeragezwa rya genetike ko kanseri yawe ifite ihinduka rya gene ya ALK. Ubu buryo bwihariye bufasha kumenya neza ko urimo guhabwa ubuvuzi bukwiye bw'ubwoko bwawe bwihariye bwa kanseri.
Brigatinib ikoreshwa cyane cyane mu kuvura ALK-positive metastatic non-small cell lung cancer (NSCLC). Ibi bivuze ko yandikirwa kanseri y'ibihaha yamaze gukwirakwira mu bindi bice by'umubiri kandi ikaba irimo impinduka zihariye za genetike.
Muganga wawe ashobora kugusaba brigatinib nk'umuti wa mbere niba warwaye kanseri y'ibihaha ya ALK-positive. Mu buryo bundi, birashobora gushyirwaho niba kanseri yawe yarateye imbere cyangwa ikaba itakigira icyo ikora ku bindi bice bya ALK nka crizotinib cyangwa ceritinib.
Uyu muti urimo no kwigwaho mu zindi nshinga za kanseri zifite impinduka za gene ya ALK, nubwo izi nshingano zifatwa nk'izigeragezwa. Umuganga wawe w'inzobere mu by'ubuvuzi azemeza niba brigatinib ikwiriye hashingiwe ku bwoko bwa kanseri yawe n'ibisubizo by'ibizamini bya genetike.
Brigatinib ikora ibara ALK protein, ikora nk'ikintu gihinduka kibi kibwira selile za kanseri gukura no kwiyongera mu buryo butagira uko bucya. Mu kubuza iyi protein, uyu muti mu by'ukuri urazimya ikimenyetso gitera kanseri gukura.
Ibi bifatwa nk'ubuvuzi bukomeye, bugamije kuko bugaba ibitero ku nzira ya molekulare itera kanseri yawe. Bitandukanye na shimi ya gakondo ikora ku selile nzima n'iza kanseri, brigatinib yateguwe kugira ngo ihitemo mu bikorwa byayo.
Uyu muti kandi ufite ibikorwa ku mpinduka zimwe na zimwe zishobora kuza iyo kanseri irwanya ibindi bice bya ALK. Ibi bituma bifite agaciro cyane mu kuvura kanseri zateye imbere kugira ngo zihunge ubundi buvuzi bugamije.
Abantu benshi batangira kubona ingaruka mu byumweru bike bya mbere by'ubuvuzi, nubwo inyungu yuzuye ishobora gufata amezi menshi kugira ngo igaragarire ku nyigo z'amashusho.
Fata brigatinib nk'uko umuganga wawe w'inzobere mu by'ubuvuzi abitegeka, akenshi rimwe ku munsi hamwe n'ibiryo cyangwa nta biryo. Urashobora kuyifata n'ikirahure cy'amazi, kandi nta bisabwa byihariye byo kuyifata n'amata cyangwa kwirinda ibiryo bimwe na bimwe.
Mimina ibinini byose utabikubaguye, utabishishimura, cyangwa ngo ubimenagure. Niba ugira ingorane zo kumira ibinini, ganira n'ikipe yawe y'ubuvuzi ku buryo bwagufasha, ariko ntukagire icyo uhindura ku binini wenyine.
Gerageza gufata brigatinib ku gihe kimwe buri munsi kugira ngo urugero ruri mu mubiri wawe rugume rumeze kimwe. Abarwayi benshi babona ko bifasha guhuza gufata imiti yabo n'akamenyero ka buri munsi, nk'ifunguro rya mu gitondo cyangwa kumesa amenyo.
Ntabwo ukeneye kurya ibiryo byihariye mbere yo gufata brigatinib, ariko kugumana imirire myiza mu gihe cyose uvurwa birashobora gufasha mu guteza imbere ubuzima bwawe muri rusange n'imbaraga zawe.
Ubusanzwe uzakomeza gufata brigatinib igihe cyose ikora neza mu kugenzura kanseri yawe kandi uyihanganira neza. Ibi bishobora kumara amezi cyangwa imyaka, bitewe n'uko kanseri yawe yitwara ku buvuzi.
Umuvuzi wawe w'indwara z'umwijima azagenzura uko urimo utera imbere akoresheje ibizamini bisanzwe n'ibizamini by'amaraso kugira ngo amenye niba umuti ukora neza. Ibi bizamini bikunze gukorwa buri mezi make, nubwo gahunda ishobora guhinduka bitewe n'uko ubuzima bwawe bumeze.
Abarwayi bamwe bakomeza gufata brigatinib igihe kirekire kanseri yabo igenda neza kandi ingaruka zikaba zigenzurwa. Abandi bashobora gukenera guhindura gahunda yabo y'ubuvuzi niba kanseri yigize imbaraga cyangwa niba ingaruka zikomeye.
Ntuzigere uhagarika gufata brigatinib utabanje kubiganiraho n'ikipe yawe y'ubuvuzi. N'iyo wumva umeze neza, guhagarika ako kanya bishobora gutuma kanseri yawe ikura vuba.
Kimwe n'imiti yose ivura kanseri, brigatinib ishobora gutera ingaruka, nubwo abarwayi benshi bazibona ko zigenzurwa n'ubufasha n'ubugenzuzi bukwiye. Kumva icyo witegura bishobora kugufasha kumva witeguye kandi ufite icyizere ku buvuzi bwawe.
Dore ingaruka zisanzwe abarwayi bahura nazo, zikora ku bantu barenga 20% bafata brigatinib:
Izi ngaruka zisanzwe zikunda gucungwa, kandi ikipe yawe y'ubuzima ishobora gutanga ingamba zo gufasha kugabanya ingaruka zabyo ku buzima bwawe bwa buri munsi.
Hariho kandi izindi ngaruka zitari nyinshi ariko zikomeye zisaba ubufasha bwihuse bw'abaganga. Nubwo ibi bigira ingaruka ku barwayi bake, ni ngombwa kubimenya:
Vugana n'umuganga wawe ako kanya niba ubonye kimwe muri ibi bimenyetso bikomeye. Guhagarika kare akenshi birinda ingorane kandi bikagufasha gukomeza kuvurwa neza.
Zimwe mu ngaruka zitari nyinshi ariko zikomeye zirimo imikorere ikabije y'uruhu n'ibibazo by'umwijima. Muganga wawe azakugenzura buri gihe akoresheje ibizamini by'amaraso kugirango amenye ibibazo byose hakiri kare.
Brigatinib ntabwo ikwiriye kuri buri wese, kandi umuganga wawe w'indwara z'umutima azagenzura neza niba ari umutekano kuri wowe bitewe n'ubuzima bwawe muri rusange n'amateka yawe y'ubuvuzi. Iyi suzuma rifasha kumenya neza ko ubona inyungu nyinshi hamwe n'ibibazo bike.
Ntabwo wagombye gufata brigatinib niba ufite allergie izwi kuri uyu muti cyangwa kuri bimwe mu bigize uyu muti. Muganga wawe azareba amateka yawe y'allergie mbere yo kugutangira uyu muti.
Abantu bafite indwara zimwe na zimwe z'umutima bashobora gukenera gukurikiranwa byihariye cyangwa ntibashobore kuba bakwiriye gufata brigatinib. Ibi birimo abafite ibibazo bikomeye by'umuvuduko w'umutima cyangwa imikorere y'umutima yagabanutse cyane.
Niba ufite ibibazo bikomeye by'umwijima cyangwa impyiko, muganga wawe ashobora gukenera guhindura urugero rwawe cyangwa agatekereza ku miti itandukanye. Gukurikiranwa buri gihe birahinduka by'ingenzi cyane muri ibi bihe.
Abagore batwite ntibagomba gufata brigatinib kuko ishobora gukomeretsa umwana ukura. Niba uri mu gihe cyo kubyara, uzakenera gukoresha uburyo bwo kuboneza urubyaro bukora neza mugihe uvurwa no mu gihe runaka nyuma yo guhagarika umuti.
Brigatinib igurishwa ku izina ry'ubwoko rya Alunbrig muri Leta Zunze Ubumwe z'Amerika no mu bindi bihugu byinshi. Ushobora kubona izina rimwe cyangwa irindi ku icupa ryawe ry'umuti cyangwa ku mpapuro z'ubwishingizi.
Uyu muti ukorwa na Takeda Pharmaceuticals, kandi ni kimwe mu bigize umuti ukora neza hatitawe niba urugero rwawe ruvuga
Ceritinib (Zykadia) ni ubundi buryo bushobora kugira akamaro ku kanseri zanze gukira kuri crizotinib. Ifite ingaruka zitandukanye, zishobora gushimisha abarwayi bamwe.
Alectinib (Alecensa) ifatwa nk'ingirakamaro cyane ku kanseri y'ibihaha ya ALK-positive kandi ishobora kugira ingaruka nke kurusha ubundi buryo. Ni nziza cyane mu kuvura kanseri yafashe ubwonko.
Lorlatinib (Lorbrena) yagenewe gutsinda ubudahangarwa ku bindi byongera ALK kandi ishobora kuvura neza metastases yo mu bwonko. Igaragaza imwe mu buryo bushya muri ubu bwoko bw'imiti.
Ubushakashatsi bwa kliniki buvuga ko brigatinib ishobora kugira akamaro kurusha crizotinib, cyane cyane ku barwayi kanseri yabo yafashe ubwonko cyangwa yateje ubudahangarwa ku bundi buvuzi. Ariko, "kuruta" biterwa n'uko ubuzima bwawe bwifashe n'uko witwara ku buvuzi.
Brigatinib isa nkaho igenzura iterambere rya kanseri mu gihe kirekire kurusha crizotinib ku barwayi benshi. Ifite kandi akamaro kanini mu kuvura kanseri yafashe ubwonko, ikaba ari ikibazo gikunze kugaragara kuri kanseri y'ibihaha ya ALK-positive.
Ariko, crizotinib imaze igihe kinini ikoreshwa kandi ifite umutekano wemejwe. Abarwayi bamwe boroherwa na crizotinib kurusha brigatinib, cyane cyane ku ngaruka zimwe na zimwe nk'umuvuduko ukabije w'amaraso.
Umuhanga wawe mu by'ubuvuzi azatekereza ku bintu nk'ubuzima bwawe muri rusange, urugero rwa kanseri yawe, imiti wabanje gufata, n'ibyo wifuza kugira ngo agushakire umuti ukwiriye.
Brigatinib ishobora kugira ingaruka ku mikorere y'umutima, bityo abantu barwaye indwara z'umutima basanzwe bakeneye isuzuma n'ubugenzuzi bwitondewe. Umuhanga wawe mu by'umutima n'umuahanga wawe mu by'ubuvuzi bazakorana kugira ngo bamenye niba bikwiriye kuri wowe.
Uyu muti ushobora gutera umuvuduko mwinshi w'amaraso n'umutima gutera gahoro ku barwayi bamwe. Niba urwaye indwara y'umutima, abaganga bawe bazakurikirana izi ngaruka cyane kandi bashobora guhindura gahunda yawe y'imiti uko bikwiye.
Abantu benshi bafite ibibazo by'umutima byoroheje kugeza ku bikomeye bashobora gufata brigatinib mu buryo bwizewe hamwe no gukurikiranwa neza. Itsinda ryawe ry'ubuzima rizagereranya inyungu zo kuvura kanseri n'ibishobora guteza ibibazo by'umutima.
Niba unyweye brigatinib nyinshi mu buryo butunganye kurusha uko byategetswe, vugana n'umuganga wawe cyangwa ikigo gishinzwe kurwanya ubumara ako kanya. Ntukegere ngo urebe niba ibimenyetso bigaragara, kuko gufata ingamba hakiri kare buri gihe ni byiza.
Kunywa brigatinib nyinshi bishobora gukomeza ingaruka ziterwa n'umuti nk'isuka, impiswi, cyangwa guhinduka k'umuvuduko w'amaraso. Kugira urupapuro rw'umuti hamwe nawe igihe uhamagaye bishobora gufasha abaganga kuguha inama zikwiye.
Kugirango wirinde kunywa imiti myinshi mu buryo butunganye, tekereza gukoresha igikoresho cyo gutegura imiti cyangwa gushyiraho ibyibutso kuri terefone kugirango bigufashe gukurikirana urugero rwawe rwa buri munsi.
Niba wirengagije urugero kandi hashize amasaha atarenze 12 uhereye igihe cyari gisanzwe, unywe urugero wirengagije ako kanya wibukije. Niba hashize amasaha arenga 12, reka urugero wirengagije hanyuma unywe urugero rwawe rukurikira ku gihe gisanzwe.
Ntuzigere unywa urugero ebyiri icyarimwe kugirango usubize urugero wirengagije, kuko ibi bishobora kongera ibyago byo kugira ingaruka ziterwa n'umuti. Ni byiza gukomeza gahunda yawe isanzwe imbere.
Niba ukunda kwibagirwa urugero, vugana n'itsinda ryawe ry'ubuzima kuri gahunda zo kugufasha kwibuka. Kunywa imiti buri gihe bifasha gukomeza urwego rwawo mu mubiri wawe.
Ukwiye guhagarika kunywa brigatinib gusa uyobowe n'umuganga wawe w'inzobere mu kuvura kanseri. Iyi myanzuro ikunze gushingira ku buryo umuti urimo kugenzura kanseri yawe n'uburyo urimo kwihanganira ingaruka zose ziterwa n'umuti.
Muganga wawe azakoresha ibizamini bisanzwe byerekana ishusho y'umubiri n'ibizamini by'amaraso kugira ngo akurikirane niba imiti igikora neza. Niba kanseri yawe itangiye kongera gukura cyangwa niba ugize ingaruka zikomeye, bashobora kugusaba guhagarika imiti cyangwa guhindura uburyo bwo kuvurwa.
N'iyo wumva umeze neza, guhagarika brigatinib utabihuguriwe na muganga byatuma kanseri yawe ikura vuba. Banza uvugane n'ikipe yawe y'ubuvuzi ku byerekeye ibibazo byose bifitanye isano n'imiti yawe.
Nubwo nta sano ridasanzwe riri hagati ya brigatinib n'inzoga, akenshi birasabwa kugabanya kunywa inzoga mugihe cyo kuvurwa kanseri. Inzoga zirashobora gutuma ingaruka zimwe na zimwe zirushaho kuba mbi kandi zishobora kubuza umubiri wawe gukora neza imiti.
Niba uhisemo kunywa inzoga rimwe na rimwe, banza ubivugane n'ikipe yawe y'ubuvuzi. Bashobora kukugira inama ku kintu gito, niba gihari, gishobora kuba gitekanye hashingiwe ku buzima bwawe muri rusange n'uburyo bwo kuvurwa.
Wibuke ko inzoga zishobora no kugira ingaruka ku mikorere y'umwijima wawe, kandi brigatinib isaba gukurikiranwa buri gihe umwijima. Kugabanya kunywa inzoga bifasha kumenya neza ibisubizo byo gukurikirana.
6Mpeople
Get clear medical guidance
on symptoms, medications, and lab reports.